Registration is open for the 2nd edition of the Brain Innovation Days, taking place on 11-12 October, 2022, in Brussels, Belgium.

The EBRA Final Conference will take place on 11 October, 2022, in Brussels, Belgium, featuring a talk from EAN President, Prof. Paul Boon on Conclusions on the brain Research Challenges and Priorities in Europe.

Here are our first two reports from the inaugural round of EAN Student Teaser Fellowships, which took place in July 2022. Find out how our future neurologists got on in their chosen departments.

A joint session between the International Federation of Clinical Neurophysiology and EAN will be held during the ICCN 2022 in September.

Read the latest reports from EAN Clinical Fellowship participants on their experiences in London and Paris.

Read the latest reports on EAN Clinical Fellowships in Ulm, Oxford and London

The EAN Mentorship Programme is about to embark on its third round of finding and matching committed pairs of mentors and mentees.

6th Rijeka Forum on Neurodegenerative Diseases “Neurodegeneration updates and the 30 years of Amyloid Cascade Hypothesis” September 25-28, 2022 This event is organised by the Clinic of Neurology UHC Rijeka together with the Croatian Academy of Sciences and Arts and… Continue Reading

The European Medicines Agency’s annual report for 2021 provides an overview of the Agency’s activities to protect and promote public (and animal) health in the European Union (EU) and highlights EMA’s most significant achievements.

Alzheimer Europe is proud to launch a special publication, to celebrate 10 years of the inspirational work of the European Working Group of People with Dementia (EWGPWD). Congratulations to the group on its 10th anniversary! The publication was launched by… Continue Reading

On 14 June 2022, Alzheimer Europe held its first in-person European Parliament Lunch Debate since February 2020, which focused on “Neurological conditions and mental health in EU and WHO Europe programmes”.

The Alzheimer Europe Anti-Stigma Award will be presented at the closing of the upcoming Alzheimer Europe Conference in Bucharest.

The new EAN President-Elect highlights some hopes and objectives for the future of the EAN, including updates on the work of the Covid-19 Task Force and the Coordinating Panel on Diversity, Equity and Inclusion in Neurology.

Our research paper of the month presents the results of the ‘SWIFT direct’ trial, a randomised, open-label, blinded-outcome trial, aiming to investigate whether thrombectomy alone would be non-inferior to thrombectomy plus intravenous alteplase in patients with acute ischaemic stroke due to anterior circulation large vessel occlusion.

The EAN Neuro-covid ReGistrY has now collected over 3,400 cases from more than 40 centres all over the world. Get involved!